segunda-feira, 18 de fevereiro de 2013

Amicus Therapeutics slumps on new Fabry drug data - Businessweek

ogarawo.wordpress.com


Amicus Therapeutics slumps on new Fabry drug data

Businessweek


NEW YORK (AP) â€" Shares of Amicus Therapeutics Inc. tumbled Friday after the company reported new negative results from a clinical trial of an experimental treatment for Fabry disease, a rare genetic disorder. Amicus said the drug, which is c »

Nenhum comentário:

Postar um comentário